AzTrials
AzTrials

Hair TransplantationCO2-FUE-PRPNCT07751523

Fractional CO₂ Laser Before Follicular Unit Extraction Hair Transplantation With Platelet-Rich Plasma for Secondary Cicatricial Alopecia

A study testing hair transplantation preceded by fractional and PRP in people with Hair Transplantation, run by Tanta University at 1 site in Egypt.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Secondary cicatricial alopecia is characterized by permanent hair loss due to destruction of hair follicles following trauma, burns, infection, or other causes. Hair transplantation using follicular unit extraction (FUE) is an established treatment; however, graft survival may be limited by poor vascularity and… Read more about this study

Who is it for?
Ages 16 to 30 years
Conditions the study is for
Hair Transplantation
What is being tested?
hair transplantation preceded by fractional and PRP
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
20 participants
Where
1 siteEgypt
Study dates
2 May 2024to 30 May 2026
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 16 to 30 years
  • All sexes
  • No healthy volunteers
  • Child, Adult

Who may be able to join

  • Patients with stable secondary cicatricial alopecia. Male or female participants. Participants with realistic expectations regarding treatment outcomes. All hair types (silky, curly, or normal hair). Presence of an adequate donor site for follicular unit extraction (FUE). Ability and willingness to provide written informed consent.

Who cannot join

  • Extremes of age. Chronic systemic diseases, including hepatic or renal disease. Receiving chemotherapy or systemic corticosteroid therapy. Platelet disorders or other blood disorders. Pregnancy or lactation. History of keloid formation. Scar duration less than 1 year. Absence of a suitable donor site for hair transplantation

Trial locations and contacts

1 site in 1 country.

Egypt1 site
  • Tanta University Hospitals

    Tanta

Other trials in Egypt

About this study

Official title: Effect of Preoperative Fractional CO₂ Laser on the Outcome of Follicular Unit Extraction Hair Transplantation Combined With Intraoperative Platelet-Rich Plasma in Patients With Secondary Cicatricial Alopecia

Secondary cicatricial alopecia is characterized by permanent hair loss due to destruction of hair follicles following trauma, burns, infection, or other causes. Hair transplantation using follicular unit extraction (FUE) is an established treatment; however, graft survival may be limited by poor vascularity and fibrosis within scar tissue. Fractional carbon dioxide (CO₂) laser has been proposed to improve the recipient site by enhancing tissue remodeling and vascularization before transplantation.

This prospective comparative clinical study evaluated the effect of three preoperative sessions of fractional CO₂ laser followed by FUE hair transplantation with intraoperative platelet-rich plasma (PRP) injection compared with FUE hair transplantation combined with intraoperative PRP alone in patients with stable secondary cicatricial alopecia. Twenty participants were allocated into two groups of 10 patients each and were followed for 9 months after hair transplantation.

The primary objective was to determine whether preoperative fractional CO₂ laser improves the clinical outcome of FUE hair transplantation in secondary cicatricial alopecia. Outcomes included clinical improvement, dermoscopic assessment of hair growth, patient satisfaction, and scar assessment.

Read the detailed description

Secondary cicatricial alopecia is characterized by permanent destruction of hair follicles resulting from trauma, burns, infection, radiation, or other non-follicular pathological processes. Hair transplantation using follicular unit extraction (FUE) is an established surgical treatment for stable secondary cicatricial alopecia; however, graft survival and cosmetic outcomes may be compromised by fibrosis, reduced vascularity, and poor tissue elasticity within scarred recipient sites. Fractional carbon dioxide (CO₂) laser has been suggested to improve scar quality by promoting tissue remodeling, neovascularization, and wound healing, potentially enhancing the recipient bed before hair transplantation. Platelet-rich plasma (PRP), which contains a high concentration of growth factors, may further improve graft survival and hair growth by stimulating tissue regeneration.

This prospective comparative clinical study was conducted to evaluate whether preoperative fractional CO₂ laser treatment improves the outcome of FUE hair transplantation combined with intraoperative PRP injection in patients with stable secondary cicatricial alopecia. Twenty participants of both sexes with stable secondary cicatricial alopecia and realistic treatment expectations were enrolled. Patients with chronic systemic diseases, pregnancy or lactation, platelet or blood disorders, history of keloid formation, scar duration less than one year, or inadequate donor sites were excluded. The study was approved by the Research Ethics Committee of Tanta University Hospitals (Approval No. 34430/1/21), and written informed consent was obtained from all participants before enrollment.

Participants were assigned into two treatment groups. Group A received three sessions of fractional CO₂ laser treatment at one-month intervals before surgery, followed one month later by FUE hair transplantation combined with intraoperative PRP injection. Group B underwent direct FUE hair transplantation combined with intraoperative PRP injection without preoperative laser treatment. PRP was prepared from autologous venous blood using a double-centrifugation technique and injected into the recipient scar tissue during the transplantation procedure. Hair grafts were harvested using the FUE technique from the donor area and transplanted into the scarred recipient site according to standard surgical protocols.

Participants were followed for nine months after hair transplantation. Clinical assessment included standardized photographic evaluation by three blinded dermatologists and two plastic surgeons. Dermoscopic examination was performed before and after treatment to evaluate follicular regeneration and the percentage of scar surface covered by growing hair. Patient satisfaction and scar severity were also assessed using validated scar assessment scales. The primary objective was to determine whether preoperative fractional CO₂ laser enhances the clinical outcome of FUE hair transplantation with intraoperative PRP in patients with secondary cicatricial alopecia. Secondary objectives included evaluation of dermoscopic hair regrowth, patient satisfaction, and changes in scar assessment scores

Being tested
hair transplantation preceded by fractional and PRP
Keywords
cicatricial alopecia, fractional CO2, PRP, Hair Transplantation
Medical subject headings
Alopecia

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • hair transplantation preceded by fractional and PRPProcedure or surgery

    intervention injection

Study groups in NCT07751523
Study groupRoleWhat they receive
fractional plus hair transplantation and PRPActive comparatorTreatment injection
Receives: Procedure: hair transplantation preceded by fractional and PRP
Hair transplantation plus PRPPlacebo comparatorPLACEBO
Receives: Procedure: hair transplantation preceded by fractional and PRP

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Clinical improvement after hair transplantation

    Excellent (>75% improvement) Good (50-75%) Fair (25-49%) Poor (<25%)

    Measured: 9 months after follicular unit extraction (FUE) hair transplantation

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted7 Aug 2026
  2. Study start2 May 2024
  3. Primary completion10 Jan 2026
  4. Study completion30 May 2026

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
20 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07751523
Sponsor's protocol ID
34430/1/21
Acronym
CO2-FUE-PRP
Status last verified
Aug 2026
First submitted
3 Aug 2026
Last updated
7 Aug 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing hair transplantation preceded by fractional and PRP in people with Hair Transplantation, run by Tanta University at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 7 Aug 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Clinical improvement after hair transplantation (time frame: 9 months after follicular unit extraction (FUE) hair transplantation). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 7 Aug 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in